Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2016.08.034DOI Listing

Publication Analysis

Top Keywords

recommendation amiodarone
4
amiodarone treatment
4
treatment symptomatic
4
symptomatic arrhythmias
4
arrhythmias associated
4
associated atrioventricular
4
atrioventricular bypass
4
bypass tracts
4
recommendation
1
treatment
1

Similar Publications

Monopolar electrocautery is usually a safe and effective technique used in laparoscopic cholecystectomy and bile duct surgery, but it may lead to adverse consequences, even ventricular fibrillation (VF). Amiodarone is an effective antiarrhythmic drug commonly used in practice to treat ventricular and atrial arrhythmias, but it may induce tachyarrhythmia or even VF. We report a case of VF occurring twice during cholecystectomy.

View Article and Find Full Text PDF

[European Society of Cardiology (ESC) guidelines on atrial fibrillation 2024 : What is new and what is important?].

Herz

November 2024

Klinik für Kardiologie, Angiologie, Intensivmedizin, Deutsches Herzzentrum der Charité, Campus Charité Mitte, Charitéplatz 1, 10117, Berlin, Deutschland.

Article Synopsis
  • * New recommendations include performing transthoracic echocardiography for newly diagnosed AF patients and suggesting SGLT2 inhibitors for heart failure management regardless of left ventricular ejection fraction.
  • * The CHA2DS2-VA score now simplifies thromboembolism risk assessment, while pulmonary vein isolation is recommended as a first-line treatment for paroxysmal AF, emphasizing the need for ongoing risk factor evaluation and treatment of related health issues.
View Article and Find Full Text PDF

Background: In the contemporary management of heart failure with reduced ejection fraction (HFrEF), the recommended quadruple guideline-directed medical therapy (GDMT) consists of angiotensin receptor-neprilysin inhibitor (ARNI), evidence-based beta-blockers (BB), mineralocorticoid receptor antagonists (MRA), and sodium-glucose cotransporter-2 inhibitors (SGLT-2i). This study explored the impact of adding implantable cardioverter-defibrillator (ICD) therapy to this comprehensive regimen in HFrEF patients.

Methods: Utilizing deidentified data from the National Electronic Database of the Turkish Ministry of Health, we conducted a nationwide retrospective cohort study on 5450 HFrEF patients receiving quadruple GDMT, including ARNI.

View Article and Find Full Text PDF

Introduction: Polypharmacy is a growing concern in healthcare systems. While available data on potential drug-drug interactions (pDDI) from emergency department (ED) patients is derived from heterogenous populations, this study specifically focused on patients with atrial fibrillation (AF). We hypothesized that patients with AF have similar comorbidities, receive similar drugs, and have similar pDDIs.

View Article and Find Full Text PDF

The impact of thyroid disorder on cardiovascular disease: Unraveling the connection and implications for patient care.

Int J Cardiol Heart Vasc

December 2024

Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, Faculty of Medicine, Padjadjaran University, Bandung, West Java 45363, Indonesia.

The thyroid gland is responsible for metabolism, as well as cardiac function and the peripheral vascular system. Thyroid dysfunctions are associated with an increase in the risk of cardiovascular diseases, including heart failure and coronary heart disease atrial fibrillation, by impairing heart contractility, stroke volume, heart rate, peripheral vascular resistance, and electrical activity. Thyroid dysfunctions also alter several cardiovascular risk factors, such as atherosclerosis, hypertension, and dyslipidemia, as well as causing stroke, which is associated with atrial fibrillation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!